webinar register page

Webinar banner
Pellets from fluid bed processes – a smart concept for high(er) potent drug processing
Manufacturing tablets is frequently a multi-step process: weighing, granulation, milling, blending, compression, coating. The efforts to provide a safe work environment for the production staff are considerably reduced when a technology platform like pellets is applied for high potent APIs.

Contact with the potent API can be limited to the weighing step. Less manufacturing steps also means: reduced risk for cross contamination.
OEL calculations for the drug products to be produced will be demonstrated. Cleaning of equipment considering GMP acceptance criteria will be discussed.
* Required information


Dr. Norbert Pöllinger
Head of Technology Development @Glatt Pharmaceutical Services
Norbert Poellinger is heading the Technology Development unit. Until 2018, he was responsible for Development and Manufacturing Services Group at Glatt Pharmaceutical Services which included Pharmaceutical Development, Manufacturing, Quality Control, Quality Assurance and Plant Engineering. He studied pharmaceutical sciences at the University of Erlangen, Germany and received a PhD degree in Pharmaceutical Technology. Currently, the recently formed Glatt Pharmaceutical Services GmbH & Co.KG focuses on controlled release and taste masked multiparticulates including minitablets and tablets. Drug products for the paediatric and geriatric population are of particular interest. Logistic services have become a new service opportunity of Glatt.